Day One Biopharmaceuticals is a company dedicated to developing and advancing medicines for patients, with a strong focus on pediatric low-grade glioma (pLGG) and pediatric cancer research. The company is committed to improving the lives of cancer patients of all ages by providing access to innovative therapies. Their pipeline includes FDA-approved medicines for pediatric oncology, and they actively engage in clinical trials, scientific publications, and research collaborations to drive progress in cancer treatment and drug development. Their mission emphasizes collaboration with stakeholders to redefine possibilities for people living with cancer from day one.
Oncology β’ Cancer β’ Drug Development β’ Biotechnology β’ Pediatric Oncology
November 12
Director for Search & Evaluation, develop treatments for pediatric oncology at Day One.